الفهرس 
Complications after radical cystectomy in Kasr AlAini hospital: 30 & 90 day morbidity & mortality (Enhanced recovery protocol versus classic protocol)
ABSTRACTOnly 14 pages are availabe for public view
 |  | from | 290 |  |  |
| | | from | 290 | | |
Abstract
Background: Radical cystectomy is still associated with greater morbidity and prolonged in-patient stay after surgery than other urological procedures. Enhanced Recovery After Surgery (ERAS) protocols are multimodal perioperative care pathways that aim to achieve early recovery after surgical procedures by maintaining preoperative organ function. There is a high potential for reducing morbidity associated with radical cystectomy by utilizing ERAS protocols. Materials and methods: This is a prospective randomized study conducted from 2014 to 2016 in patients scheduled for definitive treatment by radical cystectomy (RC), pelvic lymph node dissection (PLND) and urinary diversion. Patients were randomized in two groups: group A (enhanced recovery protocol), and group B (classic protocol). Patients were followed for 90 d postoperatively. Objective: Comparison and analysis between patients in enhanced recovery protocol and patients in classic bowel preparation protocol in important preoperative variables, important intraoperative variables, early postoperative variables as well as 90 day postoperative follow up. Results: Seventy five patients were included in our study, of whom 43 patients (57.3%) were randomized to enhanced protocol and 32 patients (42.7%) to classic protocol. The age of our patients ranged from 40-76 years. Mean was 58.49 years. 64 patients were males (85.3%), while 11 were females (14.7%), The BMI of our patients ranged from 19.1-46.88 Kg/m². Mean was 29.74 Kg/m². All complications within 90 days of surgery were recorded and graded according to an established five-grade modification of the original Clavien system , grade I 17 patients (37.8%),grade II 12 patients (26.7%) , grade IIIa two patients (5.3%) , grade IIIb 4 patients (5.3%) and grade V 10 patients (22.2%)